← Return to Clinical Trials Feed
📅 TRIAL CALENDAR
Clinical Trials Calendar 2026
50 clinical trials with confirmed start dates — sorted by most recent. Track recruiting studies across all phases, conditions, and sponsors worldwide.
TRIALS: 50 // RECRUITING: 50 // SOURCE: CLINICALTRIALS.GOV // UPDATED: DAILY
July 2026 (3 trials)
NCT07701616 N/A
Recruiting
Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder
Condition
Obsessive-Compulsive Disorder
Start Date
Jul 15, 2026
Location
China
Sponsor
Central South University
NCT07048314 Phase 1, Phase 2
Recruiting
Stem Cells for Erectile Dysfunction Post RALP
Condition
Erectile Dysfunction
Start Date
Jul 7, 2026
Location
United States
Sponsor
The Methodist Hospital Researc
NCT07640516 N/A
Recruiting
The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupi...
Condition
Analgesia Assessment
Start Date
Jul 1, 2026
Location
Egypt
Sponsor
Kasr El Aini Hospital
March 2026 (1 trials)
December 2025 (2 trials)
NCT07258121 Phase 1, Phase 2
Recruiting
Study of ZGGS34 in Participants With Advanced Solid Tumors
Condition
Solid Tumor
Start Date
Dec 31, 2025
Location
China
Sponsor
Suzhou Zelgen Biopharmaceutica
NCT07485114 N/A
Recruiting
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell C...
Condition
Renal Cell Carcinoma (Kidney Cancer)
Start Date
Dec 3, 2025
Location
Israel
Sponsor
Daniel Keizman
November 2025 (1 trials)
October 2025 (1 trials)
September 2025 (1 trials)
August 2025 (3 trials)
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Start Date
Aug 26, 2025
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
NCT06627504 N/A
Recruiting
Type 1 Diabetes REst for Metabolic Health
Condition
Type 1 Diabetes (T1D)
Start Date
Aug 12, 2025
Location
United States
Sponsor
University of Colorado, Denver
NCT07075016 Phase 3
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With New...
Condition
Acute Myeloid Leukemia
Start Date
Aug 5, 2025
Location
Austria, Belgium, Denmark
Sponsor
Stichting Hemato-Oncologie voo
June 2025 (2 trials)
NCT06860516 N/A
Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
Condition
Diabetes Mellitus, Type I
Start Date
Jun 6, 2025
Location
United States
Sponsor
GentiBio, Inc
NCT06962306 Phase 4
Recruiting
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
Condition
Cleft Palate
Start Date
Jun 4, 2025
Location
United States
Sponsor
Duke University
April 2025 (1 trials)
March 2025 (1 trials)
February 2025 (1 trials)
November 2024 (2 trials)
NCT06041763 N/A
Recruiting
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
Condition
Meniscus Tear
Start Date
Nov 20, 2024
Location
United States
Sponsor
NYU Langone Health
NCT06857604 N/A
Recruiting
The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling ...
Condition
Hematologic Diseases
Start Date
Nov 15, 2024
Location
Canada, France, Italy
Sponsor
Meyer Children's Hospital IRCC
October 2024 (2 trials)
NCT06630806 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneou...
Condition
Plasma Cell Myeloma Refractory
Start Date
Oct 30, 2024
Location
United States, Australia, Canada
Sponsor
Sanofi
NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Start Date
Oct 10, 2024
Location
United States
Sponsor
Abramson Cancer Center at Penn
July 2024 (3 trials)
NCT06392906 Phase 3
Recruiting
Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)
Condition
Thyroid Associated Ophthalmopathy
Start Date
Jul 11, 2024
Location
Thailand
Sponsor
Janjira Petsuksiri
NCT07451106 N/A
Recruiting
Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physica...
Condition
Postpartum Bladder Dysfunction
Start Date
Jul 11, 2024
Location
United States
Sponsor
University of California, San
NCT06569459 Phase 2
Recruiting
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the ...
Condition
Esophageal Cancer
Start Date
Jul 9, 2024
Location
China
Sponsor
The First Affiliated Hospital
June 2024 (3 trials)
NCT06459024 N/A
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Condition
Acute Myeloid Leukemia, in Relapse
Start Date
Jun 28, 2024
Location
Germany, Italy, Lithuania
Sponsor
Istituto Romagnolo per lo Stud
NCT06437509 Phase 2
Recruiting
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Sm...
Condition
Extensive-stage Small-cell Lung Cancer
Start Date
Jun 13, 2024
Location
China
Sponsor
Sichuan Baili Pharmaceutical C
NCT06282406 N/A
Recruiting
Pupil-Indexed Noninvasive Neuromodulation
Condition
Paresis
Start Date
Jun 3, 2024
Location
United States
Sponsor
VA Office of Research and Deve
April 2024 (1 trials)
March 2024 (1 trials)
January 2024 (1 trials)
December 2023 (1 trials)
November 2023 (2 trials)
NCT06091904 N/A
Recruiting
Effects of Sufentanil on the Intraoperative Hemodynamics
Condition
Intraoperative Hypotension
Start Date
Nov 24, 2023
Location
South Korea
Sponsor
Seoul National University Hosp
NCT06204406 N/A
Recruiting
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-spa...
Condition
Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
Start Date
Nov 23, 2023
Location
China
Sponsor
RenJi Hospital
October 2023 (1 trials)
July 2023 (1 trials)
February 2023 (2 trials)
NCT05732116 N/A
Recruiting
PTSD of Surgeons or Anesthesiologists on Prognosis of Surgical Patients
Condition
Post Traumatic Stress Disorder
Start Date
Feb 21, 2023
Location
China
Sponsor
Xijing Hospital
NCT06513416 N/A
Recruiting
Gut Microbiota and Pulmonary Complications After Non Cardiac Elective Surgery in...
Condition
Gut Microbiota
Start Date
Feb 1, 2023
Location
China
Sponsor
Peking Union Medical College H
January 2023 (2 trials)
NCT05696704 N/A
Recruiting
Telehealth to Reduce Mental Health in Family Caregivers
Condition
Mental Health Issue
Start Date
Jan 30, 2023
Location
United States
Sponsor
Texas Tech University
NCT04356287 Phase 1, Phase 2
Recruiting
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemi...
Condition
Sclerosis, Systemic
Start Date
Jan 5, 2023
Location
Canada
Sponsor
Marie Hudson, MD
December 2022 (2 trials)
NCT05917106 N/A
Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (...
Condition
Carcinoma
Start Date
Dec 26, 2022
Location
China
Sponsor
Jinling Hospital, China
NCT05319106 N/A
Recruiting
Phase Ⅱ Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Tre...
Condition
Venous Leg Ulcer
Start Date
Dec 15, 2022
Location
China
Sponsor
ShiCang Yu
August 2022 (1 trials)
June 2022 (1 trials)
May 2022 (1 trials)
January 2022 (1 trials)
November 2021 (1 trials)
February 2021 (1 trials)
January 2021 (2 trials)
NCT04628416 N/A
Recruiting
Evaluation of the PICO® Negative Pressure Dressing System on the Fibula Free Fla...
Condition
Carcinomatous Resections
Start Date
Jan 18, 2021
Location
France
Sponsor
University Hospital, Montpelli
NCT06311006 N/A
Recruiting
Safety Registry of a Fecal Microbiota Transplant Cohort
Condition
Clostridium Difficile Infections
Start Date
Jan 4, 2021
Location
France
Sponsor
Assistance Publique - Hôpitaux
January 2020 (1 trials)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology